His Cancer Meds Were Nearly $1K A Pill. How Did That Happen?
ProPublica reporter David Armstrong began investigating the pharmaceutical industry when he learned a single pill of his cancer treatment costs about the same as a new iPhone — but costs 25 cents to make. His investigation into the discovery and marketing of the drug Revlimid revealed strategies employed by pharmaceutical companies to ward off competition, and keep prices of their medications high. We'll also talk about ways insurance companies deny claims for tests and treatment recommended by doctors.
Also, David Bianculli reviews a music documentary about singer-songwriter Janis Ian.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
Also, David Bianculli reviews a music documentary about singer-songwriter Janis Ian.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
- Datum:
- Duur:
Gerelateerde podcastafleveringen
/https%3A//media.npr.org/assets/img/2022/09/23/fresh-air_tile_npr-network-01_sq-a6f7c547c8e78b8230edc7fc3c32005de3756e0d.jpg%3Fs%3D1400%26c%3D66%26f%3Djpg)
Meer afleveringen van Fresh Air
-
Zombies Frontman Colin Blundstone
There's a new documentary about the '60s British band The Zombies. It's called 'Hung Up on a Dream' and it's streaming on Amazon Prime. We're listening back to Terry's 1998 interview with lead singer of The Zombies, Colin Blundstone.... -
Navigating The 'Wellness' Epidemic
Journalist Amy Larocca says our society's obsession with optimization and self-care has reached a fever pitch. She unpacks what it really means to take care of ourselves in How to Be Well. Also, Justin Chang reviews the Chinese film... -
His Cancer Meds Were Nearly $1K A Pill. How Did That Happen?
ProPublica reporter David Armstrong began investigating the pharmaceutical industry when he learned a single pill of his cancer treatment costs about the same as a new iPhone — but costs 25 cents to make. His investigation into the...